NO20012490L - Anvendelse av staurosporinderivater for behandling av okul¶re neovaskul¶re sykdommer - Google Patents

Anvendelse av staurosporinderivater for behandling av okul¶re neovaskul¶re sykdommer

Info

Publication number
NO20012490L
NO20012490L NO20012490A NO20012490A NO20012490L NO 20012490 L NO20012490 L NO 20012490L NO 20012490 A NO20012490 A NO 20012490A NO 20012490 A NO20012490 A NO 20012490A NO 20012490 L NO20012490 L NO 20012490L
Authority
NO
Norway
Prior art keywords
treatment
ocular neovascular
neovascular diseases
staurosporin derivatives
staurosporin
Prior art date
Application number
NO20012490A
Other languages
English (en)
Other versions
NO328085B1 (no
NO20012490D0 (no
Inventor
Romulus Kimbro Brazzell
Jeanette Marjorie Wood
Peter Anthony Campochiaro
Frances Elizabeth Kane
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20012490D0 publication Critical patent/NO20012490D0/no
Publication of NO20012490L publication Critical patent/NO20012490L/no
Publication of NO328085B1 publication Critical patent/NO328085B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20012490A 1998-11-23 2001-05-21 Anvendelse av staurosporinderivater for fremstilling av et medikament for behandling av okulaere neovaskulaere sykdommer NO328085B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19867798A 1998-11-23 1998-11-23
PCT/EP1999/008987 WO2000030651A1 (en) 1998-11-23 1999-11-22 Use of staurosporine derivatives for treating ocular neovascular diseases

Publications (3)

Publication Number Publication Date
NO20012490D0 NO20012490D0 (no) 2001-05-21
NO20012490L true NO20012490L (no) 2001-06-25
NO328085B1 NO328085B1 (no) 2009-11-30

Family

ID=22734344

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012490A NO328085B1 (no) 1998-11-23 2001-05-21 Anvendelse av staurosporinderivater for fremstilling av et medikament for behandling av okulaere neovaskulaere sykdommer

Country Status (19)

Country Link
EP (1) EP1131073B1 (no)
JP (2) JP2002530342A (no)
KR (1) KR100698449B1 (no)
CN (1) CN1172673C (no)
AT (1) ATE252387T1 (no)
AU (1) AU761092B2 (no)
BR (1) BR9915569A (no)
CA (1) CA2348890C (no)
DE (1) DE69912304T2 (no)
DK (1) DK1131073T3 (no)
ES (1) ES2211197T3 (no)
HK (1) HK1040182A1 (no)
ID (1) ID29970A (no)
IL (2) IL142757A0 (no)
NO (1) NO328085B1 (no)
NZ (1) NZ511559A (no)
PT (1) PT1131073E (no)
WO (1) WO2000030651A1 (no)
ZA (1) ZA200103925B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0122318D0 (en) * 2001-09-14 2001-11-07 Novartis Ag Organic compounds
US20030119812A1 (en) * 2001-11-08 2003-06-26 Brazzell Romulus Kimbro Method for decreasing capillary permeability in the retina
WO2004009056A1 (en) * 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
CN101580515B (zh) * 2008-05-16 2011-06-08 上海医药工业研究院 一种星形孢菌素提取纯化的方法
EP2406250B1 (en) 2009-03-11 2015-08-12 Merck Sharp & Dohme Corp. Inhibitors of akt activity
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
CN102924479A (zh) * 2011-08-09 2013-02-13 山东鲁北药业有限公司 一种星孢菌素类衍生物的半合成方法
US9345705B2 (en) 2011-09-15 2016-05-24 Merck Sharp & Dohme Corp. Compositions and methods for treating cancer
ME02925B (me) 2012-11-28 2018-04-20 Merck Sharp & Dohme Kompozicije i postupci za liječenje kancera

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
CA2138644A1 (en) * 1992-07-08 1994-01-20 Bert M. Glaser Method of treating ophthalmic disorders using tgf-.beta.
US6410322B1 (en) * 1993-07-27 2002-06-25 Hybridon Inc Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
AU2066797A (en) * 1996-03-21 1997-10-10 Sugen, Inc. Assays for kdr/flk-1 receptor tyrosine kinase inhibitors
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
EP1061913B1 (en) * 1998-03-13 2007-06-27 The Johns Hopkins University School Of Medicine The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy

Also Published As

Publication number Publication date
IL142757A0 (en) 2002-03-10
CN1172673C (zh) 2004-10-27
BR9915569A (pt) 2001-08-14
JP2011088938A (ja) 2011-05-06
CN1328462A (zh) 2001-12-26
ID29970A (id) 2001-10-25
PT1131073E (pt) 2004-03-31
ATE252387T1 (de) 2003-11-15
ES2211197T3 (es) 2004-07-01
NO328085B1 (no) 2009-11-30
CA2348890A1 (en) 2000-06-02
EP1131073B1 (en) 2003-10-22
NO20012490D0 (no) 2001-05-21
NZ511559A (en) 2004-01-30
DK1131073T3 (da) 2004-02-02
CA2348890C (en) 2009-05-12
KR100698449B1 (ko) 2007-03-23
DE69912304D1 (de) 2003-11-27
AU761092B2 (en) 2003-05-29
JP2002530342A (ja) 2002-09-17
IL142757A (en) 2007-07-04
ZA200103925B (en) 2002-07-25
AU1506600A (en) 2000-06-13
DE69912304T2 (de) 2004-07-22
EP1131073A1 (en) 2001-09-12
HK1040182A1 (en) 2002-05-31
WO2000030651A1 (en) 2000-06-02
KR20010078398A (ko) 2001-08-20

Similar Documents

Publication Publication Date Title
ATE324119T1 (de) Verwendung von saccharid-konjugaten
DE69834658D1 (de) Verwendung von aminothiolverbindungen zur behandlung von nerven- und nieren-erkrankungen und der arzneimitteltoxizität
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
PT1165085E (pt) Derivados de ftalazina para tratar doencas inflamatorias
ATE323482T1 (de) Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten
BR0108175A (pt) Derivados de piperazina e piperidina para o tratamento ou a prevenção de danos neuronais
DE69940951D1 (de) Nd wachstumshemmende mittel
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
DE69305776D1 (de) Behandlung neurodegenerativer Krankheiten
NO20012490D0 (no) Anvendelse av staurosporinderivater for behandling av okul¶re neovaskul¶re sykdommer
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
NO20024486D0 (no) Forbedret behandling av neovaskularisering
DE69613386T2 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
NO20052153L (no) Piperazin- og piperidinderivater for behandling av nevrologiske sykdommer.
DE60130872D1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
WO2000009098A3 (en) Method for treating ocular neovascular diseases
PT986393E (pt) Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro
ATE428470T1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
RU94045256A (ru) Применение бензо[g]хинолинов
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
BR0215752A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees